Journal of the American Society of Nephrology
2008 JASN IMPACT FACTOR 7.505 HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP 
    advanced
CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION


Published ahead of print on August 8, 2007
J Am Soc Nephrol 18: 2457-2460, 2007
© 2007 American Society of Nephrology
doi: 10.1681/ASN.2007010062

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
ASN.2007010062v1
18/9/2457    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Desch, K.
Right arrow Articles by Motto, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Desch, K.
Right arrow Articles by Motto, D.

Science in Renal Medicine

Is There a Shared Pathophysiology for Thrombotic Thrombocytopenic Purpura and Hemolytic-Uremic Syndrome?

Karl Desch* and David Motto{dagger}

Department of Pediatrics, University of Michigan, Life Sciences Institute, Ann Arbor, Michigan; and {dagger} Departments of Internal Medicine and Pediatrics, University of Iowa, Iowa City, Iowa

Correspondence: Dr. David Motto, Departments of Internal Medicine and Pediatrics, University of Iowa, 3269C Carver Biomedical Research Building, Iowa City, IA 52242. Phone: 319-353-5630; Fax: 319-353-8383; E-mail: david-motto{at}uiowa.edu

Thrombotic microangiopathy is characterized by microvascular thrombosis coupled with thrombocytopenia, hemolytic anemia, and red blood cell fragmentation. Familiar to nephrologists and hematologists alike, classically associated with thrombotic microangiopathy are the hemolytic-uremic syndrome (HUS) and thrombotic thrombocytopenic purpura (TTP), the histories and presentations of which are closely intertwined. Not surprising, these two disorders are considered by many to be manifestations of the same disease process, whereas others consider HUS and TTP to be distinct clinical and pathologic entities. Herein are reviewed HUS and TTP along with recent progress shedding new light on possible shared pathophysiologic mechanisms for these two intriguing disorders.




This article has been cited by other articles:


Home page
J. Clin. Pathol.Home page
R John and A M Herzenberg
Renal toxicity of therapeutic drugs
J. Clin. Pathol., June 1, 2009; 62(6): 505 - 515.
[Abstract] [Full Text] [PDF]


Home page
BMJHome page
R Som, R Wynne-Simmons, J Islam, and S Lawman
A chicken sandwich leading to intensive care
BMJ, February 4, 2009; 338(feb04_2): b200 - b200.
[Full Text]




HOME CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP